Menu
D61.810

Antineoplastic chemotherapy induced pancytopenia

Instruction Source: D61.810

Antineoplastic chemotherapy induced pancytopenia

Excludes 2 (Not Included Here)

  • aplastic anemia due to antineoplastic chemotherapy (D61.1)
Instruction Source: D61.81

Pancytopenia

Excludes 1 (Mutually Exclusive)

  • pancytopenia (due to) (with) aplastic anemia (D61.9)
  • pancytopenia (due to) (with) bone marrow infiltration (D61.82)
  • pancytopenia (due to) (with) congenital (pure) red cell aplasia (D61.01)
  • pancytopenia (due to) (with) hairy cell leukemia (C91.4-)
  • pancytopenia (due to) (with) human immunodeficiency virus disease (B20.-)
  • pancytopenia (due to) (with) leukoerythroblastic anemia (D61.82)
  • pancytopenia (due to) (with) myeloproliferative disease (D47.1)

Excludes 2 (Not Included Here)

  • pancytopenia (due to) (with) myelodysplastic syndromes (D46.-)
Instruction Source: D61.8

Other specified aplastic anemias and other bone marrow failure syndromes

Instruction Source: D61

Other aplastic anemias and other bone marrow failure syndromes

Excludes 2 (Not Included Here)

  • neutropenia (D70.-)
Instruction Source: D60-D64

Aplastic and other anemias and other bone marrow failure syndromes (D60-D64)

Instruction Source: D50-D89

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

Excludes 2 (Not Included Here)

  • autoimmune disease (systemic) NOS (M35.9)
  • certain conditions originating in the perinatal period (P00-P96)
  • complications of pregnancy, childbirth and the puerperium (O00-O9A)
  • congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
  • endocrine, nutritional and metabolic diseases (E00-E88)
  • human immunodeficiency virus [HIV] disease (B20)
  • injury, poisoning and certain other consequences of external causes (S00-T88)
  • neoplasms (C00-D49)
  • symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)
← View D61.810 in Tabular List